SavedAdd your journal

Journals / European Journal of Therapeutics / 2020 / Cilt: 26 - Sayı: 3

The Neutrophil to Lymphocyte Ratio and In-Hospital All-Cause Mortality in Patients with COVID-19

Samir ALLAHVERDİYEV
Alaa QUISI
Hazar HARBALIOĞLU
Gökhan ALICI
Ömer GENÇ
Abdullah YILDIRIM
İbrahim Halil KURT
Pages
251–256
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The NLRwas calculated for each patient.Results: The NLR on admission was found to be significantly higher in nonsurvivor COVID-19 patients than survivors (12.3 [0.8–137.3] vs. 3.2 [0.6–79.0], p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In December 2019, pneumonia associated with severe acute respiratory syndrome coronavirus 2 emerged in China, andhas been spread worldwide eventuating the coronavirus disease 2019 (COVID-19) pandemic.
📊
Key Findings & Data:As of June 27, 2020, 195,883 peoplehave been diagnosed with COVID-19 in Turkey, among them 5082 are dead.
💡
Conclusion & Impact:The NLRwas calculated for each patient.Results: The NLR on admission was found to be significantly higher in nonsurvivor COVID-19 patients than survivors (12.3 [0.8–137.3] vs. 3.2 [0.6–79.0], p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: In December 2019, pneumonia associated with severe acute respiratory syndrome coronavirus 2 emerged in China, andhas been spread worldwide eventuating the coronavirus disease 2019 (COVID-19) pandemic. As of June 27, 2020, 195,883 peoplehave been diagnosed with COVID-19 in Turkey, among them 5082 are dead. Moreover, 9,999,606 people were infected worldwide.The neutrophil-to-lymphocyte ratio (NLR) has been reported as an inflammatory biomarker. This study aimed to evaluate the relationship between NLR on admission and in-hospital all-cause mortality in adult patients with COVID-19.Methods: This retrospective cohort study included a total of 455 COVID-19 patients from Turkey. The diagnosis of COVID-19 wasmade according to the World Health Organization’s interim guidance and confirmed by RNA detection of SARS-CoV-2. The NLRwas calculated for each patient.Results: The NLR on admission was found to be significantly higher in nonsurvivor COVID-19 patients than survivors (12.3 [0.8–137.3] vs. 3.2 [0.6–79.0], p

🔖

Cite This Article

ALLAHVERDİYEV, S., QUISI, A., HARBALIOĞLU, H., ALICI, G., GENÇ, Ö., YILDIRIM, A., KURT, İ. H. (2022). The Neutrophil to Lymphocyte Ratio and In-Hospital All-Cause Mortality in Patients with COVID-19. European Journal of Therapeutics, Cilt: 26 - Sayı: 3, 251–256. https://ajindex.com/articles/512210

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020
  2. [Crossref] 2. Faria SS, Fernandes Jr PC, Silva MJ, Lima VC, Fontes W, Freitas-Junior R, et al. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience 2016
  3. [Crossref] 3. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 2012
  4. [Crossref] 4. de Jager CP, Wever PC, Gemen EF, Kusters R, van Gageldonk-Lafeber AB, van der Poll T, et al. The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One 2012
  5. e46561. [Crossref] 5. Curbelo J, Rajas O, Arnalich B, Galvan-Roman JM, Luquero-Bueno S, Ortega-Gomez M, et al. Neutrophil Count Percentage and Neutrophil-Lymphocyte Ratio as Prognostic Markers in Patients Hospitalized for Community-Acquired Pneumonia. Arch Bronconeumol 2019
  6. [Crossref] 6. Kaushik R, Gupta M, Sharma M, Jash D, Jain N, Sinha N, et al. Diagnostic and Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Early and Late Phase of Sepsis. Indian J Crit Care Med 2018
  7. [Crossref] 7. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect 2020
  8. e6-e12. [Crossref] 8. Liu J, Liu Y, Xiang P, Pu L, Xiong H, Li C, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med 2020
  9. [Crossref] 9. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020
  10. [Crossref] 10. Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis 2020. [Crossref] 11. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol 2017
  11. [Crossref] 12. He Z, Zhao C, Dong Q, Zhuang H, Song S, Peng G, et al. Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets. Int J Infect Dis 2005
  12. [Crossref] 13. Min CK, Cheon S, Ha NY, Sohn KM, Kim Y, Aigeri